Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGE smoking cessation trial of varenicline with or without intensive counseling
NL-OMON23449Active, not recruiting
- Sponsor
- Department of General Practice, CAPHRI, Maastricht University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Department of General Practice, CAPHRI, Maastricht University. Primary endpoint: Prolonged smoking abstinence from week 9 to week 26. Started Sep 2011; status: active, not recruiting.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NL-OMON23449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23449.